Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

Increased Brain Protein Levels Linked to Alzheimer’s Disease

 

September 15, 2010  |   

Elevated levels of a growth protein in the brains of Alzheimer’s disease (AD) patients is linked to impaired neurogenesis, the process by which new neurons are generated, say researchers at the University of California, San Diego in today’s edition of The Journal of Neuroscience.

Eliezer Masliah

Eliezer Masliah, MD

Eliezer Masliah, MD, professor of neurosciences and pathology in the UC San Diego School of Medicine and colleagues report that increased levels of BMP6 – part of a family of bone morphogenetic proteins involved in cell signaling and growth – were found in the brains of Alzheimer’s patients and in mouse models of the disease.

BMP6 is primarily known to be involved in bone growth and the proliferation of non-neuronal glial cells in developing embryos. Its purpose in adult brains is less clear. “As a growth factor, it might initially be expressed for protective effect, a response to accumulating amyloid plaque proteins in Alzheimer’s patients,” said first author Leslie Crews, a post-doctoral researcher in Masliah’s lab.

But too much BMP6 appears to be increasingly detrimental. Researchers found that levels of BMP6 grew in step with the progression of Alzheimer’s disease. “In early stages of AD, there was less protein than there was in later, more advanced stages,” said Crews.

Higher-than-normal levels of BMP6 were found in the dentate gyrus of Alzheimer’s patients and around characteristic amyloid plaques in the hippocampus. Both regions of the brain are critical to memory formation and storage.

In cell cultures, the scientists found that BMP6 reduced the proliferation of cells, a discovery that suggests the protein could be a potential therapeutic target. “The next step is to see what happens when we normalize expression of BMP6,” said Masliah. “If we can do that, it may possible to impact this part of AD’s pathogenesis.”

The protein provides an easier target than some molecules, said Crews, because it is secreted and circulates around cells in the brain. “We don’t have to figure out how to get it into the brain and into cells,” she said.

Co-authors of the study are Anthony Adame, Christina Patrick, Alexandra DeLaney, Emiley Pham and Edward Rockenstein of the Department of Neurosciences at UC San Diego and Lawrence Hansen of the Departments of Neurosciences and Pathology at UCSD.

# # #

Media Contact: Scott LaFee, 619-543-6163, slafee@ucsd.edu



Media Contact

Related News

4/22/2015
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year ...
4/20/2015
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and p ...
4/20/2015
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Die ...
4/20/2015
The threat of falsified medications, also referred to as counterfeit, fraudulent, and substandard, can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researc ...
4/17/2015
Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices us ...
4/16/2015
The increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation t ...
4/16/2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardi ...
4/13/2015
About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at Universit ...